TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

Benzinga Logo Benzinga By Vandana Singh
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

President Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices for obesity and diabetes drugs, expanding Medicare and Medicaid coverage starting mid-2026 at $245 per month with $50 copays.

Insights
QBTS.WS   negative

Portrayed as a risky pure-play quantum computing stock with uncertain future prospects


LLY   positive

Company will receive relief from potential tariffs, obtain FDA vouchers, and reduce drug prices, making treatments more accessible